Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? PRO

由 Derebail, Vimal K.
發表在 Kidney360 (2021)

Sickle-Cell Trait: Novel Clinical Significance

由 Key, Nigel S., Derebail, Vimal K.
出版 2010

The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait

由 Naik, Rakhi P., Derebail, Vimal K.
發表在 Expert Rev Hematol (2017)

Negative Health Implications Of Sickle Cell Trait in High Income Countries: From The Football Field To The Laboratory

由 Key, Nigel S., Connes, Philippe, Derebail, Vimal K.
發表在 Br J Haematol (2015)

The Authors Reply

由 Bomback, Andrew S., Derebail, Vimal K., Kshirsagar, Abhijit V.
發表在 Kidney Int (2010)

The glomerulopathy of sickle cell disease

由 Ataga, Kenneth I, Derebail, Vimal K, Archer, David R
發表在 Am J Hematol (2014)

Role of Direct Oral Anticoagulants in Patients with Kidney Disease

由 Derebail, Vimal K., Rheault, Michelle N., Kerlin, Bryce A.
發表在 Kidney Int (2019)

Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA–salt hypertensive rats

由 Pollock, David M., Derebail, Vimal K., Yamamoto, Tatsuo, Pollock, Jennifer S.
出版 2000

Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis

由 Jain, Koyal, Jawa, Pankaj, Derebail, Vimal K., Falk, Ronald J.
發表在 Kidney360 (2020)

A rare cause of the pulmonary-renal syndrome: a case of atypical haemolytic-uraemic syndrome complicated by pulmonary haemorrhage

由 Derebail, Vimal K., Parikh, Palak, Jennette, J. Charles, Kshirsagar, Abhijit V.
出版 2008

The Authors Reply

由 Lee, Taewoo, Derebail, Vimal K., Reich, Heather N., Nachman, Patrick H.
發表在 Kidney Int Rep (2020)

Polyomavirus Nephropathy: Quantitative Urinary Polyomavirus-Haufen Testing Accurately Predicts the Degree of Intrarenal Viral Disease

由 Singh, Harsharan K., Reisner, Howard, Derebail, Vimal K., Kozlowski, Tomasz, Nickeleit, Volker
發表在 Transplantation (2015)

Rapid decline in estimated glomerular filtration rate is common in adults with sickle cell disease and associated with increased mortality

由 Derebail, Vimal K., Zhou, Qingning, Ciccone, Emily J., Cai, Jianwen, Ataga, Kenneth I.
發表在 Br J Haematol (2019)

Incidence and Prediction of Immune Checkpoint Inhibitor Related Nephrotoxicity

由 Sorah, Jonathan D., Rose, Tracy L., Radhakrishna, Roshni, Derebail, Vimal K., Milowsky, Matthew I.
發表在 J Immunother (2021)

Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease

由 Laurin, Louis-Philippe, Nachman, Patrick H., Desai, Payal C., Ataga, Kenneth I., Derebail, Vimal K.
出版 2014

Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on Progression of Glomerulopathy in Sickle Cell Disease

由 Thrower, Ashley, Ciccone, Emily J, Maitra, Poulami, Derebail, Vimal K., Cai, Jianwen, Ataga, Kenneth I.
發表在 Br J Haematol (2018)

Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy

由 Reynolds, Monica L., Nachman, Patrick H., Mooberry, Micah J., Crona, Daniel J., Derebail, Vimal K.
發表在 J Nephrol (2018)

High Prevalence of Sickle Cell Trait in African Americans with ESRD

由 Derebail, Vimal K., Nachman, Patrick H., Key, Nigel S., Ansede, Heather, Falk, Ronald J., Kshirsagar, Abhijit V.
出版 2010

Diagnostic Significance of Peritubular Capillary Basement Membrane Multilaminations in Kidney Allografts: Old Concepts Revisited

由 Liapis, George, Singh, Harsharan K., Derebail, Vimal K., Gasim, Adil M.H., Kozlowski, Tomasz, Nickeleit, Volker
出版 2012

The Case | Acute kidney injury in a patient with P. carinii pneumonia

由 Derebail, Vimal K., McGregor, JulieAnne G., Colindres, Romulo E., Singh, Harsharan K., Kshirsagar, Abhijit V.
出版 2009